Why Isn’t the Angiotensin Type 1 Receptor a Target in Cancer?

Oncotarget - United States
doi 10.18632/oncotarget.15682
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

The Angiotensin II Type 1 Receptor and Receptor-Associated Proteins

Cell Research
Cell BiologyMolecular Biology
2001English

Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs With Angiotensin Type 1 Receptor

English

Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Why Isn’t Every Physicist a Bayesian?

American Journal of Physics
AstronomyPhysics
1995English

Polymorphisms of the Angiotensin II Type 1 Receptor Gene Affect Antihypertensive Response to Angiotensin Receptor Blockers in Hypertensive Chinese

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Angiotensin 2 Type 2 Receptor Blockade Is a Novel Target for Murine Osteoarthritis Pain

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Angiotensin II Upregulates Acyl-CoA:Cholesterol Acyltransferase-1 via the Angiotensin II Type 1 Receptor in Human Monocyte-Macrophages

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2008English

Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent

Hypertension
Internal Medicine
2010English

Angiotensin II Type-1 Receptor Blockers Enhance the Effects of Bevacizumab-Based Chemotherapy in Metastatic Colorectal Cancer Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy